Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 7051 - 7075 of 7769 in total

(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE

Experimental

Firocoxib

Firocoxib is a cycooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug. It currently approved for veterinary use in dogs and horses under the brand names Equioxx and Previcox. Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses. Firocoxib is not intended or approved for use...
Experimental
Vet approved

5-beta-D-ribofuranosylnicotinamide adenine dinucleotide

Experimental

Tasisulam

Tasisulam has been used in trials studying the treatment and basic science of Melanoma, Lymphoma, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others.
Investigational

Methanesulfonyl Fluoride

Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety.
Investigational

1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea

Experimental

(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE

Experimental

Dansylamide

Experimental

Sulfadicramide

Experimental

Aconitate Ion

Experimental

N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide

Experimental

N-{3-[4-(3-amino-propyl)-piperazin-1-yl]-propyl}-3-nitro-5-(galactopyranosyl)-beta-benzamide

Experimental

CGP 4832

Experimental

Dexamethasone isonicotinate

Dexamethasone isonicotinate is an anti-inflammatory, anti-allergic glucocorticoid that can be administered orally, by inhalation, topically, and parenterally. Its unintended mineralocorticoid action may cause salt and water retention.
Vet approved

3,5-Difluorobenzenesulfonamide

Experimental

ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE

Experimental

2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide

Experimental

Cilnidipine

Cilnidipine is a dihydropyridine calcium antagonist. It was jointly developed by Fuji Viscera Pharmaceutical Company, Japan and Ajinomoto, Japan and approved in 1995. Compared with other calcium antagonists, cilnidipine can act on the N-type calcium channel that existing sympathetic nerve end besides acting on L-type calcium channel that similar to...
Investigational

Niludipine

Niludipine is a calcium channel blocker.
Experimental

N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide

Experimental

1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM

Experimental

Glufosfamide

Investigational

3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one

Experimental

(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE

Experimental

5-(2-methylpiperazine-1-sulfonyl)isoquinoline

Experimental
Displaying drugs 7051 - 7075 of 7769 in total